Radiotherapy-Induced Nausea and Vomiting Treatment Market Size, Share and Report Analysis By Drug Class (5-HT3 Receptor Antagonists, NK1 Receptor Antagonists, Corticosteroids, Dopamine Antagonists, Benzodiazepines, Cannabinoids, Combination Therapies), By Emetogenic Risk Level (Moderate Emetogenic Radiotherapy, High Emetogenic Radiotherapy, Low Emetogenic Radiotherapy, Minimal Emetogenic Radiotherapy), By Route of Administration (Oral, Intravenous, Transdermal, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By End User (Hospitals & Cancer Centers, Specialty Oncology Clinics, Ambulatory Care Centers, Homecare Settings), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2026-2035

Published date: Aug 2026
Report ID: 84417
Number of Pages: 301
Format:

Fact Checked

Cite this Research

Table of Content
- 1. Research Methodology and Data Source
  - 1.1. Methodology/Research Approach
  - 1.2. Market Size Estimation
  - 1.3. Market Breakdown and Data Triangulation
  - 1.4. Data Sources
  - 1.5. Secondary Sources
  - 1.6. Primary Sources
- 2. Executive Summary
  - 2.1. Taxonomy
  - 2.2. Global Market Outlook
  - 2.3. Key Facts and Figures
  - 2.4. Major Players in Radiotherapy Induced Nausea And Vomiting Treatment Market
- 3. Global Market Overview
  - 3.1. Industry Overview
  - 3.2. Segmental Overview
  - 3.3. Regional Overview
  - 3.4. Market Dynamics
    
    3.4.1. Drivers
    
    3.4.2. Restraints
    
    3.4.3. Opportunities
    
    3.4.4. Trends
  - 3.5. Regulatory Framework
  - 3.6. Opportunity Map Analysis
  - 3.7. Opportunity Orbits
  - 3.8. Market Investment Feasibility Index
  - 3.9. PESTLE Analysis
  - 3.10. PORTER’S Five Force Analysis
  - 3.11. Drivers & Restraints Impact Analysis
  - 3.12. Patient Journey Mapping
  - 3.13. Technological Landscape
  - 3.14. Product Life Cycle Analysis
  - 3.15. Value Chain Analysis
    
    3.15.1. List of Raw Material Suppliers
    
    3.15.2. List of Radiotherapy Induced Nausea And Vomiting Treatment Manufacturers
    
    3.15.3. List of Dealer/Distributors
    
    3.15.4. List of Potential Customers
  - 3.16. Cost Structure Analysis
  - 3.17. Regional Market Share and BPS Analysis
- 4. Macro-economic Factors
- 5. Impact of Current Geopolitical Scenario
- 6. Global Radiotherapy Induced Nausea And Vomiting Treatment Market Analysis and Forecast, By Drug Class
  - 6.1. Key Findings
  - 6.2. Global Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    
    6.2.1. 5-HT3 Receptor Antagonists
    
    6.2.2. NK1 Receptor Antagonists
    
    6.2.3. Corticosteroids
    
    6.2.4. Dopamine Antagonists
    
    6.2.5. Benzodiazepines
    
    6.2.6. Cannabinoids
    
    6.2.7. Combination Therapies
  - 6.3. Global Radiotherapy Induced Nausea And Vomiting Treatment Market Attractiveness Analysis, By Drug Class
- 7. Global Radiotherapy Induced Nausea And Vomiting Treatment Market Analysis and Forecast, By Emetogenic Risk Level
  - 7.1. Key Findings
  - 7.2. Global Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Emetogenic Risk Level, 2020-2035
    
    7.2.1. Moderate Emetogenic Radiotherapy
    
    7.2.2. High Emetogenic Radiotherapy
    
    7.2.3. Low Emetogenic Radiotherapy
    
    7.2.4. Minimal Emetogenic Radiotherapy
  - 7.3. Global Radiotherapy Induced Nausea And Vomiting Treatment Market Attractiveness Analysis, By Emetogenic Risk Level
- 8. Global Radiotherapy Induced Nausea And Vomiting Treatment Market Analysis and Forecast, By Route of Administration
  - 8.1. Key Findings
  - 8.2. Global Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    
    8.2.1. Oral
    
    8.2.2. Intravenous
    
    8.2.3. Transdermal
    
    8.2.4. Others
  - 8.3. Global Radiotherapy Induced Nausea And Vomiting Treatment Market Attractiveness Analysis, By Route of Administration
- 9. Global Radiotherapy Induced Nausea And Vomiting Treatment Market Analysis and Forecast, By Distribution Channel
  - 9.1. Key Findings
  - 9.2. Global Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
    
    9.2.1. Hospital Pharmacies
    
    9.2.2. Retail Pharmacies
    
    9.2.3. Online Pharmacies
  - 9.3. Global Radiotherapy Induced Nausea And Vomiting Treatment Market Attractiveness Analysis, By Distribution Channel
- 10. Global Radiotherapy Induced Nausea And Vomiting Treatment Market Analysis and Forecast, By End User
  - 10.1. Key Findings
  - 10.2. Global Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
    
    10.2.1. Hospitals & Cancer Centers
    
    10.2.2. Specialty Oncology Clinics
    
    10.2.3. Ambulatory Care Centers
    
    10.2.4. Homecare Settings
  - 10.3. Global Radiotherapy Induced Nausea And Vomiting Treatment Market Attractiveness Analysis, By End User
- 11. Global Radiotherapy Induced Nausea And Vomiting Treatment Market Analysis and Forecast, By Region
  - 11.1. Key Findings
  - 11.2. Global Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Region, 2020-2035
    
    11.2.1. North America
    
    11.2.2. Europe
    
    11.2.3. Asia Pacific
    
    11.2.4. Middle East & Africa
    
    11.2.5. Latin America
  - 11.3. Global Radiotherapy Induced Nausea And Vomiting Treatment Market Attractiveness Analysis, By Region
- 12. North America Radiotherapy Induced Nausea And Vomiting Treatment Market Analysis and Forecast, 2020-2035
  - 12.1. Key Findings
  - 12.2. North America Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
  - 12.3. North America Radiotherapy Induced Nausea And Vomiting Treatment Market Attractiveness Analysis, By Drug Class
  - 12.4. North America Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Emetogenic Risk Level, 2020-2035
  - 12.5. North America Radiotherapy Induced Nausea And Vomiting Treatment Market Attractiveness Analysis, By Emetogenic Risk Level
  - 12.6. North America Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
  - 12.7. North America Radiotherapy Induced Nausea And Vomiting Treatment Market Attractiveness Analysis, By Route of Administration
  - 12.8. North America Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
  - 12.9. North America Radiotherapy Induced Nausea And Vomiting Treatment Market Attractiveness Analysis, By Distribution Channel
  - 12.10. North America Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
  - 12.11. North America Radiotherapy Induced Nausea And Vomiting Treatment Market Attractiveness Analysis, By End User
  - 12.12. North America Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Country, 2020-2035
  - 12.13. North America Radiotherapy Induced Nausea And Vomiting Treatment Market Attractiveness Analysis, By Country
    
    12.13.1. The US Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    
    12.13.2. The US Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Emetogenic Risk Level, 2020-2035
    
    12.13.3. The US Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    
    12.13.4. The US Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
    
    12.13.5. The US Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
    
    12.13.6. Canada Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    
    12.13.7. Canada Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Emetogenic Risk Level, 2020-2035
    
    12.13.8. Canada Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    
    12.13.9. Canada Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
    
    12.13.10. Canada Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
- 13. Europe Radiotherapy Induced Nausea And Vomiting Treatment Market Analysis and Forecast, 2020-2035
  - 13.1. Key Findings
  - 13.2. Europe Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
  - 13.3. Europe Radiotherapy Induced Nausea And Vomiting Treatment Market Attractiveness Analysis, By Drug Class
  - 13.4. Europe Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Emetogenic Risk Level, 2020-2035
  - 13.5. Europe Radiotherapy Induced Nausea And Vomiting Treatment Market Attractiveness Analysis, By Emetogenic Risk Level
  - 13.6. Europe Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
  - 13.7. Europe Radiotherapy Induced Nausea And Vomiting Treatment Market Attractiveness Analysis, By Route of Administration
  - 13.8. Europe Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
  - 13.9. Europe Radiotherapy Induced Nausea And Vomiting Treatment Market Attractiveness Analysis, By Distribution Channel
  - 13.10. Europe Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
  - 13.11. Europe Radiotherapy Induced Nausea And Vomiting Treatment Market Attractiveness Analysis, By End User
  - 13.12. Europe Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Country, 2020-2035
  - 13.13. Europe Radiotherapy Induced Nausea And Vomiting Treatment Market Attractiveness Analysis, By Country
    
    13.13.1. Germany Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    
    13.13.2. Germany Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Emetogenic Risk Level, 2020-2035
    
    13.13.3. Germany Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    
    13.13.4. Germany Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
    
    13.13.5. Germany Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
    
    13.13.6. The U.K. Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    
    13.13.7. The U.K. Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Emetogenic Risk Level, 2020-2035
    
    13.13.8. The U.K. Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    
    13.13.9. The U.K. Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
    
    13.13.10. The U.K. Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
    
    13.13.11. France Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    
    13.13.12. France Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Emetogenic Risk Level, 2020-2035
    
    13.13.13. France Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    
    13.13.14. France Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
    
    13.13.15. France Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
    
    13.13.16. Spain Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    
    13.13.17. Spain Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Emetogenic Risk Level, 2020-2035
    
    13.13.18. Spain Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    
    13.13.19. Spain Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
    
    13.13.20. Spain Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
    
    13.13.21. Italy Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    
    13.13.22. Italy Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Emetogenic Risk Level, 2020-2035
    
    13.13.23. Italy Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    
    13.13.24. Italy Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
    
    13.13.25. Italy Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
    
    13.13.26. Russia & CIS Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    
    13.13.27. Russia & CIS Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Emetogenic Risk Level, 2020-2035
    
    13.13.28. Russia & CIS Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    
    13.13.29. Russia & CIS Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
    
    13.13.30. Russia & CIS Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
    
    13.13.31. Rest of Europe Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    
    13.13.32. Rest of Europe Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Emetogenic Risk Level, 2020-2035
    
    13.13.33. Rest of Europe Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    
    13.13.34. Rest of Europe Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
    
    13.13.35. Rest of Europe Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
- 14. Asia Pacific Radiotherapy Induced Nausea And Vomiting Treatment Market Analysis and Forecast, 2020-2035
  - 14.1. Key Findings
  - 14.2. Asia Pacific Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
  - 14.3. Asia Pacific Radiotherapy Induced Nausea And Vomiting Treatment Market Attractiveness Analysis, By Drug Class
  - 14.4. Asia Pacific Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Emetogenic Risk Level, 2020-2035
  - 14.5. Asia Pacific Radiotherapy Induced Nausea And Vomiting Treatment Market Attractiveness Analysis, By Emetogenic Risk Level
  - 14.6. Asia Pacific Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
  - 14.7. Asia Pacific Radiotherapy Induced Nausea And Vomiting Treatment Market Attractiveness Analysis, By Route of Administration
  - 14.8. Asia Pacific Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
  - 14.9. Asia Pacific Radiotherapy Induced Nausea And Vomiting Treatment Market Attractiveness Analysis, By Distribution Channel
  - 14.10. Asia Pacific Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
  - 14.11. Asia Pacific Radiotherapy Induced Nausea And Vomiting Treatment Market Attractiveness Analysis, By End User
  - 14.12. Asia Pacific Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Country, 2020-2035
  - 14.13. Asia Pacific Radiotherapy Induced Nausea And Vomiting Treatment Market Attractiveness Analysis, By Country
    
    14.13.1. China Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    
    14.13.2. China Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Emetogenic Risk Level, 2020-2035
    
    14.13.3. China Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    
    14.13.4. China Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
    
    14.13.5. China Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
    
    14.13.6. India Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    
    14.13.7. India Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Emetogenic Risk Level, 2020-2035
    
    14.13.8. India Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    
    14.13.9. India Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
    
    14.13.10. India Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
    
    14.13.11. Japan Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    
    14.13.12. Japan Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Emetogenic Risk Level, 2020-2035
    
    14.13.13. Japan Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    
    14.13.14. Japan Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
    
    14.13.15. Japan Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
    
    14.13.16. South Korea Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    
    14.13.17. South Korea Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Emetogenic Risk Level, 2020-2035
    
    14.13.18. South Korea Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    
    14.13.19. South Korea Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
    
    14.13.20. South Korea Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
    
    14.13.21. ASEAN Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    
    14.13.22. ASEAN Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Emetogenic Risk Level, 2020-2035
    
    14.13.23. ASEAN Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    
    14.13.24. ASEAN Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
    
    14.13.25. ASEAN Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
    
    14.13.26. Australia & New Zealand Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    
    14.13.27. Australia & New Zealand Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Emetogenic Risk Level, 2020-2035
    
    14.13.28. Australia & New Zealand Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    
    14.13.29. Australia & New Zealand Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
    
    14.13.30. Australia & New Zealand Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
    
    14.13.31. Rest of Asia Pacific Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    
    14.13.32. Rest of Asia Pacific Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Emetogenic Risk Level, 2020-2035
    
    14.13.33. Rest of Asia Pacific Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    
    14.13.34. Rest of Asia Pacific Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
    
    14.13.35. Rest of Asia Pacific Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
- 15. Middle East & Africa Radiotherapy Induced Nausea And Vomiting Treatment Market Analysis and Forecast, 2020-2035
  - 15.1. Key Findings
  - 15.2. Middle East & Africa Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
  - 15.3. Middle East & Africa Radiotherapy Induced Nausea And Vomiting Treatment Market Attractiveness Analysis, By Drug Class
  - 15.4. Middle East & Africa Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Emetogenic Risk Level, 2020-2035
  - 15.5. Middle East & Africa Radiotherapy Induced Nausea And Vomiting Treatment Market Attractiveness Analysis, By Emetogenic Risk Level
  - 15.6. Middle East & Africa Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
  - 15.7. Middle East & Africa Radiotherapy Induced Nausea And Vomiting Treatment Market Attractiveness Analysis, By Route of Administration
  - 15.8. Middle East & Africa Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
  - 15.9. Middle East & Africa Radiotherapy Induced Nausea And Vomiting Treatment Market Attractiveness Analysis, By Distribution Channel
  - 15.10. Middle East & Africa Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
  - 15.11. Middle East & Africa Radiotherapy Induced Nausea And Vomiting Treatment Market Attractiveness Analysis, By End User
  - 15.12. Middle East & Africa Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Country, 2020-2035
  - 15.13. Middle East & Africa Radiotherapy Induced Nausea And Vomiting Treatment Market Attractiveness Analysis, By Country
    
    15.13.1. GCC Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    
    15.13.2. GCC Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Emetogenic Risk Level, 2020-2035
    
    15.13.3. GCC Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    
    15.13.4. GCC Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
    
    15.13.5. GCC Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
    
    15.13.6. South Africa Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    
    15.13.7. South Africa Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Emetogenic Risk Level, 2020-2035
    
    15.13.8. South Africa Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    
    15.13.9. South Africa Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
    
    15.13.10. South Africa Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
    
    15.13.11. Rest of Middle East & Africa Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    
    15.13.12. Rest of Middle East & Africa Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Emetogenic Risk Level, 2020-2035
    
    15.13.13. Rest of Middle East & Africa Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    
    15.13.14. Rest of Middle East & Africa Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
    
    15.13.15. Rest of Middle East & Africa Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
- 16. Latin America Radiotherapy Induced Nausea And Vomiting Treatment Market Analysis and Forecast, 2020-2035
  - 16.1. Key Findings
  - 16.2. Latin America Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
  - 16.3. Latin America Radiotherapy Induced Nausea And Vomiting Treatment Market Attractiveness Analysis, By Drug Class
  - 16.4. Latin America Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Emetogenic Risk Level, 2020-2035
  - 16.5. Latin America Radiotherapy Induced Nausea And Vomiting Treatment Market Attractiveness Analysis, By Emetogenic Risk Level
  - 16.6. Latin America Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
  - 16.7. Latin America Radiotherapy Induced Nausea And Vomiting Treatment Market Attractiveness Analysis, By Route of Administration
  - 16.8. Latin America Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
  - 16.9. Latin America Radiotherapy Induced Nausea And Vomiting Treatment Market Attractiveness Analysis, By Distribution Channel
  - 16.10. Latin America Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
  - 16.11. Latin America Radiotherapy Induced Nausea And Vomiting Treatment Market Attractiveness Analysis, By End User
  - 16.12. Latin America Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Country, 2020-2035
  - 16.13. Latin America Radiotherapy Induced Nausea And Vomiting Treatment Market Attractiveness Analysis, By Country
    
    16.13.1. Brazil Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    
    16.13.2. Brazil Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Emetogenic Risk Level, 2020-2035
    
    16.13.3. Brazil Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    
    16.13.4. Brazil Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
    
    16.13.5. Brazil Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
    
    16.13.6. Mexico Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    
    16.13.7. Mexico Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Emetogenic Risk Level, 2020-2035
    
    16.13.8. Mexico Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    
    16.13.9. Mexico Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
    
    16.13.10. Mexico Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
    
    16.13.11. Rest of Latin America Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    
    16.13.12. Rest of Latin America Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Emetogenic Risk Level, 2020-2035
    
    16.13.13. Rest of Latin America Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    
    16.13.14. Rest of Latin America Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
    
    16.13.15. Rest of Latin America Radiotherapy Induced Nausea And Vomiting Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
- 17. Competitive Landscape & Company Profiles
  - 17.1. Market Competition Scenario Analysis, By Company
  - 17.2. Competitor Landscape
  - 17.3. Company Share Analysis
  - 17.4. Company Profiles
    
    17.4.1. Merck & Co., Inc.
    
    17.4.1.1. Company Details
    
    17.4.1.2. Business Overview
    
    17.4.1.3. Product Portfolio
    
    17.4.1.4. Financial Insights
    
    17.4.1.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    17.4.1.6. SWOT Analysis
    
    17.4.1.7. Geographic Footprint
    
    17.4.2. Roche Holding AG (Genentech)
    
    17.4.2.1. Company Details
    
    17.4.2.2. Business Overview
    
    17.4.2.3. Product Portfolio
    
    17.4.2.4. Financial Insights
    
    17.4.2.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    17.4.2.6. SWOT Analysis
    
    17.4.2.7. Geographic Footprint
    
    17.4.3. GlaxoSmithKline plc
    
    17.4.3.1. Company Details
    
    17.4.3.2. Business Overview
    
    17.4.3.3. Product Portfolio
    
    17.4.3.4. Financial Insights
    
    17.4.3.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    17.4.3.6. SWOT Analysis
    
    17.4.3.7. Geographic Footprint
    
    17.4.4. Pfizer Inc.
    
    17.4.4.1. Company Details
    
    17.4.4.2. Business Overview
    
    17.4.4.3. Product Portfolio
    
    17.4.4.4. Financial Insights
    
    17.4.4.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    17.4.4.6. SWOT Analysis
    
    17.4.4.7. Geographic Footprint
    
    17.4.5. Sanofi S.A.
    
    17.4.5.1. Company Details
    
    17.4.5.2. Business Overview
    
    17.4.5.3. Product Portfolio
    
    17.4.5.4. Financial Insights
    
    17.4.5.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    17.4.5.6. SWOT Analysis
    
    17.4.5.7. Geographic Footprint
    
    17.4.6. Tesaro, Inc. (GSK)
    
    17.4.6.1. Company Details
    
    17.4.6.2. Business Overview
    
    17.4.6.3. Product Portfolio
    
    17.4.6.4. Financial Insights
    
    17.4.6.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    17.4.6.6. SWOT Analysis
    
    17.4.6.7. Geographic Footprint
    
    17.4.7. Heron Therapeutics, Inc.
    
    17.4.7.1. Company Details
    
    17.4.7.2. Business Overview
    
    17.4.7.3. Product Portfolio
    
    17.4.7.4. Financial Insights
    
    17.4.7.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    17.4.7.6. SWOT Analysis
    
    17.4.7.7. Geographic Footprint
    
    17.4.8. Helsinn Group
    
    17.4.8.1. Company Details
    
    17.4.8.2. Business Overview
    
    17.4.8.3. Product Portfolio
    
    17.4.8.4. Financial Insights
    
    17.4.8.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    17.4.8.6. SWOT Analysis
    
    17.4.8.7. Geographic Footprint
    
    17.4.9. Eisai Co., Ltd.
    
    17.4.9.1. Company Details
    
    17.4.9.2. Business Overview
    
    17.4.9.3. Product Portfolio
    
    17.4.9.4. Financial Insights
    
    17.4.9.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    17.4.9.6. SWOT Analysis
    
    17.4.9.7. Geographic Footprint
    
    17.4.10. Hikma Pharmaceuticals PLC
    
    17.4.10.1. Company Details
    
    17.4.10.2. Business Overview
    
    17.4.10.3. Product Portfolio
    
    17.4.10.4. Financial Insights
    
    17.4.10.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    17.4.10.6. SWOT Analysis
    
    17.4.10.7. Geographic Footprint
    
    17.4.11. Sun Pharmaceutical Industries Ltd.
    
    17.4.11.1. Company Details
    
    17.4.11.2. Business Overview
    
    17.4.11.3. Product Portfolio
    
    17.4.11.4. Financial Insights
    
    17.4.11.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    17.4.11.6. SWOT Analysis
    
    17.4.11.7. Geographic Footprint
    
    17.4.12. Teva Pharmaceutical Industries Ltd.
    
    17.4.12.1. Company Details
    
    17.4.12.2. Business Overview
    
    17.4.12.3. Product Portfolio
    
    17.4.12.4. Financial Insights
    
    17.4.12.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    17.4.12.6. SWOT Analysis
    
    17.4.12.7. Geographic Footprint
List of Tables
- Table 1: Global Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
- Table 2: Global Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Emetogenic Risk Level, 2020-2035
- Table 3: Global Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
- Table 4: Global Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Distribution Channel, 2020-2035
- Table 5: Global Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By End User, 2020-2035
- Table 6: Global Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Region, 2020-2035
- Table 7: North America Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
- Table 8: North America Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Emetogenic Risk Level, 2020-2035
- Table 9: North America Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
- Table 10: North America Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Distribution Channel, 2020-2035
- Table 11: North America Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By End User, 2020-2035
- Table 12: North America Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Country, 2020-2035
- Table 13: The US Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
- Table 14: The US Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Emetogenic Risk Level, 2020-2035
- Table 15: The US Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
- Table 16: The US Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Distribution Channel, 2020-2035
- Table 17: The US Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By End User, 2020-2035
- Table 18: Canada Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
- Table 19: Canada Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Emetogenic Risk Level, 2020-2035
- Table 20: Canada Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
- Table 21: Canada Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Distribution Channel, 2020-2035
- Table 22: Canada Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By End User, 2020-2035
- Table 23: Europe Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
- Table 24: Europe Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Emetogenic Risk Level, 2020-2035
- Table 25: Europe Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
- Table 26: Europe Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Distribution Channel, 2020-2035
- Table 27: Europe Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By End User, 2020-2035
- Table 28: Europe Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Country, 2020-2035
- Table 29: Germany Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
- Table 30: Germany Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Emetogenic Risk Level, 2020-2035
- Table 31: Germany Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
- Table 32: Germany Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Distribution Channel, 2020-2035
- Table 33: Germany Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By End User, 2020-2035
- Table 34: The U.K. Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
- Table 35: The U.K. Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Emetogenic Risk Level, 2020-2035
- Table 36: The U.K. Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
- Table 37: The U.K. Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Distribution Channel, 2020-2035
- Table 38: The U.K. Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By End User, 2020-2035
- Table 39: France Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
- Table 40: France Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Emetogenic Risk Level, 2020-2035
- Table 41: France Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
- Table 42: France Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Distribution Channel, 2020-2035
- Table 43: France Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By End User, 2020-2035
- Table 44: Spain Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
- Table 45: Spain Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Emetogenic Risk Level, 2020-2035
- Table 46: Spain Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
- Table 47: Spain Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Distribution Channel, 2020-2035
- Table 48: Spain Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By End User, 2020-2035
- Table 49: Italy Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
- Table 50: Italy Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Emetogenic Risk Level, 2020-2035
- Table 51: Italy Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
- Table 52: Italy Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Distribution Channel, 2020-2035
- Table 53: Italy Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By End User, 2020-2035
- Table 54: Russia & CIS Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
- Table 55: Russia & CIS Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Emetogenic Risk Level, 2020-2035
- Table 56: Russia & CIS Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
- Table 57: Russia & CIS Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Distribution Channel, 2020-2035
- Table 58: Russia & CIS Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By End User, 2020-2035
- Table 59: Rest of Europe Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
- Table 60: Rest of Europe Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Emetogenic Risk Level, 2020-2035
- Table 61: Rest of Europe Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
- Table 62: Rest of Europe Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Distribution Channel, 2020-2035
- Table 63: Rest of Europe Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By End User, 2020-2035
- Table 64: Asia Pacific Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
- Table 65: Asia Pacific Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Emetogenic Risk Level, 2020-2035
- Table 66: Asia Pacific Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
- Table 67: Asia Pacific Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Distribution Channel, 2020-2035
- Table 68: Asia Pacific Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By End User, 2020-2035
- Table 69: Asia Pacific Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Country, 2020-2035
- Table 70: China Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
- Table 71: China Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Emetogenic Risk Level, 2020-2035
- Table 72: China Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
- Table 73: China Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Distribution Channel, 2020-2035
- Table 74: China Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By End User, 2020-2035
- Table 75: India Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
- Table 76: India Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Emetogenic Risk Level, 2020-2035
- Table 77: India Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
- Table 78: India Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Distribution Channel, 2020-2035
- Table 79: India Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By End User, 2020-2035
- Table 80: Japan Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
- Table 81: Japan Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Emetogenic Risk Level, 2020-2035
- Table 82: Japan Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
- Table 83: Japan Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Distribution Channel, 2020-2035
- Table 84: Japan Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By End User, 2020-2035
- Table 85: South Korea Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
- Table 86: South Korea Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Emetogenic Risk Level, 2020-2035
- Table 87: South Korea Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
- Table 88: South Korea Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Distribution Channel, 2020-2035
- Table 89: South Korea Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By End User, 2020-2035
- Table 90: ASEAN Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
- Table 91: ASEAN Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Emetogenic Risk Level, 2020-2035
- Table 92: ASEAN Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
- Table 93: ASEAN Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Distribution Channel, 2020-2035
- Table 94: ASEAN Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By End User, 2020-2035
- Table 95: Australia & New Zealand Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
- Table 96: Australia & New Zealand Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Emetogenic Risk Level, 2020-2035
- Table 97: Australia & New Zealand Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
- Table 98: Australia & New Zealand Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Distribution Channel, 2020-2035
- Table 99: Australia & New Zealand Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By End User, 2020-2035
- Table 100: Rest of Asia Pacific Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
- Table 101: Rest of Asia Pacific Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Emetogenic Risk Level, 2020-2035
- Table 102: Rest of Asia Pacific Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
- Table 103: Rest of Asia Pacific Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Distribution Channel, 2020-2035
- Table 104: Rest of Asia Pacific Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By End User, 2020-2035
- Table 105: Middle East & Africa Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
- Table 106: Middle East & Africa Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Emetogenic Risk Level, 2020-2035
- Table 107: Middle East & Africa Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
- Table 108: Middle East & Africa Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Distribution Channel, 2020-2035
- Table 109: Middle East & Africa Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By End User, 2020-2035
- Table 110: Middle East & Africa Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Country, 2020-2035
- Table 111: GCC Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
- Table 112: GCC Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Emetogenic Risk Level, 2020-2035
- Table 113: GCC Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
- Table 114: GCC Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Distribution Channel, 2020-2035
- Table 115: GCC Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By End User, 2020-2035
- Table 116: South Africa Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
- Table 117: South Africa Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Emetogenic Risk Level, 2020-2035
- Table 118: South Africa Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
- Table 119: South Africa Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Distribution Channel, 2020-2035
- Table 120: South Africa Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By End User, 2020-2035
- Table 121: Rest of Middle East & Africa Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
- Table 122: Rest of Middle East & Africa Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Emetogenic Risk Level, 2020-2035
- Table 123: Rest of Middle East & Africa Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
- Table 124: Rest of Middle East & Africa Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Distribution Channel, 2020-2035
- Table 125: Rest of Middle East & Africa Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By End User, 2020-2035
- Table 126: Latin America Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
- Table 127: Latin America Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Emetogenic Risk Level, 2020-2035
- Table 128: Latin America Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
- Table 129: Latin America Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Distribution Channel, 2020-2035
- Table 130: Latin America Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By End User, 2020-2035
- Table 131: Latin America Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Country, 2020-2035
- Table 132: Brazil Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
- Table 133: Brazil Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Emetogenic Risk Level, 2020-2035
- Table 134: Brazil Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
- Table 135: Brazil Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Distribution Channel, 2020-2035
- Table 136: Brazil Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By End User, 2020-2035
- Table 137: Mexico Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
- Table 138: Mexico Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Emetogenic Risk Level, 2020-2035
- Table 139: Mexico Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
- Table 140: Mexico Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Distribution Channel, 2020-2035
- Table 141: Mexico Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By End User, 2020-2035
- Table 142: Rest of Latin America Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
- Table 143: Rest of Latin America Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Emetogenic Risk Level, 2020-2035
- Table 144: Rest of Latin America Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
- Table 145: Rest of Latin America Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By Distribution Channel, 2020-2035
- Table 146: Rest of Latin America Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), By End User, 2020-2035
List of Figures
- Figure 1: Global Radiotherapy Induced Nausea And Vomiting Treatment Market Value (US$ Bn), 2020-2035
- Figure 2: Global Radiotherapy Induced Nausea And Vomiting Treatment Market Value Share (%) Analysis, By Drug Class, 2025 & 2035
- Figure 3: Global Radiotherapy Induced Nausea And Vomiting Treatment Market Value Share (%) Analysis, By Emetogenic Risk Level, 2025 & 2035
- Figure 4: Global Radiotherapy Induced Nausea And Vomiting Treatment Market Value Share (%) Analysis, By Route of Administration, 2025 & 2035
- Figure 5: Global Radiotherapy Induced Nausea And Vomiting Treatment Market Value Share (%) Analysis, By Distribution Channel, 2025 & 2035
- Figure 6: Global Radiotherapy Induced Nausea And Vomiting Treatment Market Value Share (%) Analysis, By End User, 2025 & 2035
- Figure 7: Global Radiotherapy Induced Nausea And Vomiting Treatment Market Value Share (%) Analysis, By Region, 2025 & 2035
- Figure 8: Global Radiotherapy Induced Nausea And Vomiting Treatment Market Value Share (%) Analysis, By Drug Class, 2020, 2025 and 2035
- Figure 9: Global Radiotherapy Induced Nausea And Vomiting Treatment Market Attractiveness Analysis, By Drug Class
- Figure 10: Global Radiotherapy Induced Nausea And Vomiting Treatment Market Value Share (%) Analysis, By Emetogenic Risk Level, 2020, 2025 and 2035
- Figure 11: Global Radiotherapy Induced Nausea And Vomiting Treatment Market Attractiveness Analysis, By Emetogenic Risk Level
- Figure 12: Global Radiotherapy Induced Nausea And Vomiting Treatment Market Value Share (%) Analysis, By Route of Administration, 2020, 2025 and 2035
- Figure 13: Global Radiotherapy Induced Nausea And Vomiting Treatment Market Attractiveness Analysis, By Route of Administration
- Figure 14: Global Radiotherapy Induced Nausea And Vomiting Treatment Market Value Share (%) Analysis, By Distribution Channel, 2020, 2025 and 2035
- Figure 15: Global Radiotherapy Induced Nausea And Vomiting Treatment Market Attractiveness Analysis, By Distribution Channel
- Figure 16: Global Radiotherapy Induced Nausea And Vomiting Treatment Market Value Share (%) Analysis, By End User, 2020, 2025 and 2035
- Figure 17: Global Radiotherapy Induced Nausea And Vomiting Treatment Market Attractiveness Analysis, By End User
- Figure 18: Global Radiotherapy Induced Nausea And Vomiting Treatment Market Value Share (%) Analysis, By Region, 2020, 2025 and 2035
- Figure 19: Global Radiotherapy Induced Nausea And Vomiting Treatment Market Attractiveness Analysis, By Region
- Figure 20: North America Radiotherapy Induced Nausea And Vomiting Treatment Market Value Share (%) Analysis, By Drug Class, 2020, 2025 and 2035
- Figure 21: North America Radiotherapy Induced Nausea And Vomiting Treatment Market Attractiveness Analysis, By Drug Class
- Figure 22: North America Radiotherapy Induced Nausea And Vomiting Treatment Market Value Share (%) Analysis, By Emetogenic Risk Level, 2020, 2025 and 2035
- Figure 23: North America Radiotherapy Induced Nausea And Vomiting Treatment Market Attractiveness Analysis, By Emetogenic Risk Level
- Figure 24: North America Radiotherapy Induced Nausea And Vomiting Treatment Market Value Share (%) Analysis, By Route of Administration, 2020, 2025 and 2035
- Figure 25: North America Radiotherapy Induced Nausea And Vomiting Treatment Market Attractiveness Analysis, By Route of Administration
- Figure 26: North America Radiotherapy Induced Nausea And Vomiting Treatment Market Value Share (%) Analysis, By Distribution Channel, 2020, 2025 and 2035
- Figure 27: North America Radiotherapy Induced Nausea And Vomiting Treatment Market Attractiveness Analysis, By Distribution Channel
- Figure 28: North America Radiotherapy Induced Nausea And Vomiting Treatment Market Value Share (%) Analysis, By End User, 2020, 2025 and 2035
- Figure 29: North America Radiotherapy Induced Nausea And Vomiting Treatment Market Attractiveness Analysis, By End User
- Figure 30: North America Radiotherapy Induced Nausea And Vomiting Treatment Market Value Share (%) Analysis, By Country, 2020, 2025 and 2035
- Figure 31: North America Radiotherapy Induced Nausea And Vomiting Treatment Market Attractiveness Analysis, By Country
- Figure 32: Europe Radiotherapy Induced Nausea And Vomiting Treatment Market Value Share (%) Analysis, By Drug Class, 2020, 2025 and 2035
- Figure 33: Europe Radiotherapy Induced Nausea And Vomiting Treatment Market Attractiveness Analysis, By Drug Class
- Figure 34: Europe Radiotherapy Induced Nausea And Vomiting Treatment Market Value Share (%) Analysis, By Emetogenic Risk Level, 2020, 2025 and 2035
- Figure 35: Europe Radiotherapy Induced Nausea And Vomiting Treatment Market Attractiveness Analysis, By Emetogenic Risk Level
- Figure 36: Europe Radiotherapy Induced Nausea And Vomiting Treatment Market Value Share (%) Analysis, By Route of Administration, 2020, 2025 and 2035
- Figure 37: Europe Radiotherapy Induced Nausea And Vomiting Treatment Market Attractiveness Analysis, By Route of Administration
- Figure 38: Europe Radiotherapy Induced Nausea And Vomiting Treatment Market Value Share (%) Analysis, By Distribution Channel, 2020, 2025 and 2035
- Figure 39: Europe Radiotherapy Induced Nausea And Vomiting Treatment Market Attractiveness Analysis, By Distribution Channel
- Figure 40: Europe Radiotherapy Induced Nausea And Vomiting Treatment Market Value Share (%) Analysis, By End User, 2020, 2025 and 2035
- Figure 41: Europe Radiotherapy Induced Nausea And Vomiting Treatment Market Attractiveness Analysis, By End User
- Figure 42: Europe Radiotherapy Induced Nausea And Vomiting Treatment Market Value Share (%) Analysis, By Country, 2020, 2025 and 2035
- Figure 43: Europe Radiotherapy Induced Nausea And Vomiting Treatment Market Attractiveness Analysis, By Country
- Figure 44: Asia Pacific Radiotherapy Induced Nausea And Vomiting Treatment Market Value Share (%) Analysis, By Drug Class, 2020, 2025 and 2035
- Figure 45: Asia Pacific Radiotherapy Induced Nausea And Vomiting Treatment Market Attractiveness Analysis, By Drug Class
- Figure 46: Asia Pacific Radiotherapy Induced Nausea And Vomiting Treatment Market Value Share (%) Analysis, By Emetogenic Risk Level, 2020, 2025 and 2035
- Figure 47: Asia Pacific Radiotherapy Induced Nausea And Vomiting Treatment Market Attractiveness Analysis, By Emetogenic Risk Level
- Figure 48: Asia Pacific Radiotherapy Induced Nausea And Vomiting Treatment Market Value Share (%) Analysis, By Route of Administration, 2020, 2025 and 2035
- Figure 49: Asia Pacific Radiotherapy Induced Nausea And Vomiting Treatment Market Attractiveness Analysis, By Route of Administration
- Figure 50: Asia Pacific Radiotherapy Induced Nausea And Vomiting Treatment Market Value Share (%) Analysis, By Distribution Channel, 2020, 2025 and 2035
- Figure 51: Asia Pacific Radiotherapy Induced Nausea And Vomiting Treatment Market Attractiveness Analysis, By Distribution Channel
- Figure 52: Asia Pacific Radiotherapy Induced Nausea And Vomiting Treatment Market Value Share (%) Analysis, By End User, 2020, 2025 and 2035
- Figure 53: Asia Pacific Radiotherapy Induced Nausea And Vomiting Treatment Market Attractiveness Analysis, By End User
- Figure 54: Asia Pacific Radiotherapy Induced Nausea And Vomiting Treatment Market Value Share (%) Analysis, By Country, 2020, 2025 and 2035
- Figure 55: Asia Pacific Radiotherapy Induced Nausea And Vomiting Treatment Market Attractiveness Analysis, By Country
- Figure 56: Middle East & Africa Radiotherapy Induced Nausea And Vomiting Treatment Market Value Share (%) Analysis, By Drug Class, 2020, 2025 and 2035
- Figure 57: Middle East & Africa Radiotherapy Induced Nausea And Vomiting Treatment Market Attractiveness Analysis, By Drug Class
- Figure 58: Middle East & Africa Radiotherapy Induced Nausea And Vomiting Treatment Market Value Share (%) Analysis, By Emetogenic Risk Level, 2020, 2025 and 2035
- Figure 59: Middle East & Africa Radiotherapy Induced Nausea And Vomiting Treatment Market Attractiveness Analysis, By Emetogenic Risk Level
- Figure 60: Middle East & Africa Radiotherapy Induced Nausea And Vomiting Treatment Market Value Share (%) Analysis, By Route of Administration, 2020, 2025 and 2035
- Figure 61: Middle East & Africa Radiotherapy Induced Nausea And Vomiting Treatment Market Attractiveness Analysis, By Route of Administration
- Figure 62: Middle East & Africa Radiotherapy Induced Nausea And Vomiting Treatment Market Value Share (%) Analysis, By Distribution Channel, 2020, 2025 and 2035
- Figure 63: Middle East & Africa Radiotherapy Induced Nausea And Vomiting Treatment Market Attractiveness Analysis, By Distribution Channel
- Figure 64: Middle East & Africa Radiotherapy Induced Nausea And Vomiting Treatment Market Value Share (%) Analysis, By End User, 2020, 2025 and 2035
- Figure 65: Middle East & Africa Radiotherapy Induced Nausea And Vomiting Treatment Market Attractiveness Analysis, By End User
- Figure 66: Middle East & Africa Radiotherapy Induced Nausea And Vomiting Treatment Market Value Share (%) Analysis, By Country, 2020, 2025 and 2035
- Figure 67: Middle East & Africa Radiotherapy Induced Nausea And Vomiting Treatment Market Attractiveness Analysis, By Country
- Figure 68: Latin America Radiotherapy Induced Nausea And Vomiting Treatment Market Value Share (%) Analysis, By Drug Class, 2020, 2025 and 2035
- Figure 69: Latin America Radiotherapy Induced Nausea And Vomiting Treatment Market Attractiveness Analysis, By Drug Class
- Figure 70: Latin America Radiotherapy Induced Nausea And Vomiting Treatment Market Value Share (%) Analysis, By Emetogenic Risk Level, 2020, 2025 and 2035
- Figure 71: Latin America Radiotherapy Induced Nausea And Vomiting Treatment Market Attractiveness Analysis, By Emetogenic Risk Level
- Figure 72: Latin America Radiotherapy Induced Nausea And Vomiting Treatment Market Value Share (%) Analysis, By Route of Administration, 2020, 2025 and 2035
- Figure 73: Latin America Radiotherapy Induced Nausea And Vomiting Treatment Market Attractiveness Analysis, By Route of Administration
- Figure 74: Latin America Radiotherapy Induced Nausea And Vomiting Treatment Market Value Share (%) Analysis, By Distribution Channel, 2020, 2025 and 2035
- Figure 75: Latin America Radiotherapy Induced Nausea And Vomiting Treatment Market Attractiveness Analysis, By Distribution Channel
- Figure 76: Latin America Radiotherapy Induced Nausea And Vomiting Treatment Market Value Share (%) Analysis, By End User, 2020, 2025 and 2035
- Figure 77: Latin America Radiotherapy Induced Nausea And Vomiting Treatment Market Attractiveness Analysis, By End User
- Figure 78: Latin America Radiotherapy Induced Nausea And Vomiting Treatment Market Value Share (%) Analysis, By Country, 2020, 2025 and 2035
- Figure 79: Latin America Radiotherapy Induced Nausea And Vomiting Treatment Market Attractiveness Analysis, By Country
- Merck & Co. Inc.
- Roche Holding AG (Genentech)
- GlaxoSmithKline plc
- Pfizer Inc.
- Sanofi S.A.
- Tesaro Inc. (GSK)
- Heron Therapeutics Inc.
- Helsinn Group
- Eisai Co. Ltd.
- Hikma Pharmaceuticals PLC
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.